These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12454879)

  • 1. Hormonal therapy in angiodysplasia: should we completely abandon its use?
    Madanick RD; Barkin JS
    Gastroenterology; 2002 Dec; 123(6):2156; author reply 2156-7. PubMed ID: 12454879
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal therapy for gastrointestinal angiodysplasia.
    Hodgson H
    Lancet; 2002 May; 359(9318):1630-1. PubMed ID: 12020519
    [No Abstract]   [Full Text] [Related]  

  • 3. Avoid hormones in gastrointestinal angiodysplasia.
    Grant EC
    Lancet; 2002 Oct; 360(9341):1254. PubMed ID: 12401283
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
    Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
    Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thalidomide therapy for gastrointestinal angiodysplasia].
    Bélard E; Foss CH; Christensen LA; Schmidt P; Nøjgaard C
    Ugeskr Laeger; 2009 Nov; 171(47):3454-5. PubMed ID: 19925735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Judicious usage of estrogen/progesterone for angiodysplasia.
    Takenaka T; Kanno Y; Suzuki H
    Artif Organs; 2005 Jan; 29(1):88-9. PubMed ID: 15644090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide in angiodysplasia-related bleeding.
    Boey JP; Hahn U; Sagheer S; McRae SJ
    Intern Med J; 2015 Sep; 45(9):972-6. PubMed ID: 26332623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone therapy with estrogen patches for the treatment of recurrent digestive hemorrhages in uremic patients].
    Alarcón MC; Fernández Lucas M; Teruel JL; Ortuño J
    Nefrologia; 2002; 22(2):208-9. PubMed ID: 12085426
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol.
    Draper K; Kale P; Martin B; Kelly Cordero R; Ha R; Banerjee D
    J Heart Lung Transplant; 2015 Jan; 34(1):132-134. PubMed ID: 25447569
    [No Abstract]   [Full Text] [Related]  

  • 10. [Octreotide and angiodysplasia].
    Fernández Salazar LI; de la Calle Valverde F; González Hernández JM
    Gastroenterol Hepatol; 2004 Nov; 27(9):558-9. PubMed ID: 15544743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intestinal angiodysplasia as the cause of recurring gastrointestinal hemorrhage].
    Schulte F
    Dtsch Med Wochenschr; 1996 Apr; 121(15):500. PubMed ID: 8605846
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide for the treatment of bleeding angiodysplasias.
    Shurafa M; Kamboj G
    Am J Gastroenterol; 2003 Jan; 98(1):221-2. PubMed ID: 12526972
    [No Abstract]   [Full Text] [Related]  

  • 13. Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis--a case history.
    Schwartz J; Rozenfeld V; Habot B
    Angiology; 1992 Mar; 43(3 Pt 1):244-8. PubMed ID: 1575371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia.
    Junquera F; Feu F; Papo M; Videla S; Armengol JR; Bordas JM; Saperas E; Piqué JM; Malagelada JR
    Gastroenterology; 2001 Nov; 121(5):1073-9. PubMed ID: 11677198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal angiodysplasia in constitutional thrombocytopathies.
    Bellucci S; Caen JP
    Int J Hematol; 1997 Jun; 65(4):419-20. PubMed ID: 9195784
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of multiple small bowel angiodysplasias causing severe life-threatening bleeding with thalidomide.
    Kirkham SE; Lindley KJ; Elawad MA; Blanshard C; Shah N
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):585-7. PubMed ID: 16707986
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy.
    Jimenez-Saenz M; Romero-Vazquez J; Caunedo-Alvarez A; Maldonado-Perez B; Gutierrez JM
    Dig Liver Dis; 2010 Mar; 42(3):232-3. PubMed ID: 19574114
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide for treatment of bleeding angiodysplasias during hemodialysis.
    Mimidis K; Kaliontzidou M; Tzimas T; Papadopoulos V
    Ren Fail; 2008; 30(10):1040-1. PubMed ID: 19016158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary hypertension in a patient with talidomide].
    Hurtado García R; García Rodríguez M
    Farm Hosp; 2013; 37(3):267-9. PubMed ID: 23789805
    [No Abstract]   [Full Text] [Related]  

  • 20. In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y.
    Hakim A; Feuerstein JD
    Ann Intern Med; 2024 Mar; 177(3):JC32. PubMed ID: 38437700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.